Amundi Pioneer Asset Management Inc. increased its stake in Waters Co. (NYSE:WAT) by 359.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 157,768 shares of the medical instruments supplier’s stock after purchasing an additional 123,464 shares during the quarter. Amundi Pioneer Asset Management Inc. owned approximately 0.20% of Waters worth $30,479,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of WAT. Brown Advisory Securities LLC bought a new stake in shares of Waters in the 4th quarter worth approximately $202,000. Checchi Capital Advisers LLC bought a new stake in shares of Waters in the 4th quarter worth approximately $210,000. Zions Bancorporation raised its holdings in shares of Waters by 12,075.0% in the 3rd quarter. Zions Bancorporation now owns 1,461 shares of the medical instruments supplier’s stock worth $262,000 after purchasing an additional 1,449 shares during the period. Contravisory Investment Management Inc. bought a new stake in shares of Waters in the 4th quarter worth approximately $290,000. Finally, Zeke Capital Advisors LLC bought a new stake in shares of Waters in the 3rd quarter worth approximately $303,000. 94.51% of the stock is currently owned by institutional investors.
In related news, SVP Terrence P. Kelly sold 1,312 shares of the company’s stock in a transaction on Friday, March 9th. The shares were sold at an average price of $212.52, for a total value of $278,826.24. Following the completion of the transaction, the senior vice president now directly owns 5,130 shares in the company, valued at $1,090,227.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Christopher A. Kuebler sold 416 shares of the company’s stock in a transaction on Thursday, March 8th. The stock was sold at an average price of $209.00, for a total transaction of $86,944.00. Following the completion of the transaction, the director now owns 15,327 shares of the company’s stock, valued at $3,203,343. The disclosure for this sale can be found here. Insiders have sold a total of 75,180 shares of company stock valued at $16,326,519 over the last 90 days. Company insiders own 5.07% of the company’s stock.
A number of research firms recently commented on WAT. BTIG Research reaffirmed a “buy” rating on shares of Waters in a report on Thursday, January 25th. Zacks Investment Research cut shares of Waters from a “buy” rating to a “hold” rating in a report on Tuesday, March 20th. ValuEngine raised shares of Waters from a “hold” rating to a “buy” rating in a report on Monday, March 19th. Robert W. Baird boosted their target price on shares of Waters from $219.00 to $220.00 and gave the company an “outperform” rating in a report on Wednesday, January 24th. Finally, JPMorgan Chase boosted their target price on shares of Waters from $180.00 to $200.00 and gave the company a “neutral” rating in a report on Wednesday, January 24th. Twelve investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $205.13.
Shares of WAT traded down $2.67 during mid-day trading on Monday, reaching $195.98. 557,485 shares of the stock traded hands, compared to its average volume of 505,516. The firm has a market capitalization of $15,650.53, a P/E ratio of 26.49, a price-to-earnings-growth ratio of 2.38 and a beta of 0.93. The company has a debt-to-equity ratio of 0.85, a current ratio of 7.04 and a quick ratio of 6.60. Waters Co. has a 1 year low of $154.15 and a 1 year high of $220.20.
Waters (NYSE:WAT) last released its quarterly earnings results on Tuesday, January 23rd. The medical instruments supplier reported $2.51 EPS for the quarter, beating analysts’ consensus estimates of $2.44 by $0.07. The firm had revenue of $687.28 million during the quarter, compared to analyst estimates of $671.98 million. Waters had a net margin of 0.88% and a return on equity of 24.70%. The business’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same period in the previous year, the business earned $2.21 EPS. analysts expect that Waters Co. will post 8.16 earnings per share for the current year.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.